• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

R1 Acquires Cerner RevWorks to Extend Revenue Cycle Capabilities

Share:

June 9, 2020

R1 RCM Inc., a provider of technology-enabled revenue cycle management services to healthcare providers, today announced that it will acquire Cerner RevWorks services business and commercial, non-federal client relationships. R1’s electronic health record-agnostic revenue cycle platform seamlessly complements a healthcare organization’s infrastructure, quickly driving transformative improvements to net patient revenue and cash flows while reducing operating costs.

Integration Between R1 and Cerner

As part of the transaction, Cerner will extend R1’s comprehensive revenue cycle capabilities and expertise to Cerner clients and new prospects, helping drive sustainable financial improvements for providers while enhancing their patients’ overall experience. RevWorks associates will be offered positions with R1, and both companies have committed to a seamless integration between the company’s technology-enabled services platform and Cerner’s software.

“We look forward to working collaboratively with Cerner to deliver superior results for healthcare providers and the communities they serve,” said Gary Long, executive vice president and chief commercial officer of R1. “With our interoperable technology and end-to-end platform, we are well-positioned to serve Cerner’s customers, as well as other healthcare organizations across the country.”

Cerner is committed to growth and transformation that drives simplicity, scale and more cost-effective solutions for health care. Our new relationship with R1 will bring our commercial, non-federal clients a total solution that pairs Cerner’s advanced technology with R1’s world-class revenue services, ultimately optimizing financial performance for health systems. Cerner remains committed to and heavily invested in its revenue cycle solutions to help our clients combine clinical, financial and operational health information when and where it’s needed.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Cerner official statement

Financial details of the acquisition were not disclosed. Centerview Partners LLC acted as financial advisor and Kirkland & Ellis LLP acted as legal advisor to R1. Greenhill & Co., LLC acted as an advisor to Cerner. The closing of the acquisition is expected to take place in the third quarter of 2020, subject to customary closing conditions.

Source: HIT Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Circle Pharma Raises $45 Million in Series B FinancingCircle Pharma Raises $45 Million in Series B Financing
  • NovAccess Global Acquires StemVax Therapeutics from Innovest GlobalNovAccess Global Acquires StemVax Therapeutics from Innovest Global
  • Xeris Pharmaceuticals Stockholders Approve Acquisition of Strongbridge BiopharmaXeris Pharmaceuticals Stockholders Approve Acquisition of Strongbridge Biopharma
  • Medical Gas Market Growth, Share, Trend, Business Opportunities, Manufacturers and Research Methodology By 2029Medical Gas Market Growth, Share, Trend, Business Opportunities, Manufacturers and Research Methodology By 2029
  • Medidata, TriNetX, Datavant Partner to Accelerate Use of RWDMedidata, TriNetX, Datavant Partner to Accelerate Use of RWD
  • Virtual Behavioral Health Company Valera Health Scores $44.5MVirtual Behavioral Health Company Valera Health Scores $44.5M
  • Telecare May Boost Homebound Seniors’ Medication Adherence According to JAMA StudyTelecare May Boost Homebound Seniors’ Medication Adherence According to JAMA Study
  • Insights on the Bioherbicide Global Market to 2026 – Featuring Deer Creek Holdings, Hindustan Bio-Tech and Verdesian Life Sciences Among Others – ResearchAndMarkets.comInsights on the Bioherbicide Global Market to 2026 – Featuring Deer Creek Holdings, Hindustan Bio-Tech and Verdesian Life Sciences Among Others – ResearchAndMarkets.com

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications